Mankind Pharma Limited has informed the Exchange about General Updates
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has received a voluntary ESG rating of 'Crisil ESG 57' from CRISIL ESG Ratings & Analytics Limited, a SEBI-registered ESG Rating Provider. The rating is based on publicly disclosed information for the fiscal year 2025. Under CRISIL's classification, a score between 51–60 falls in the 'Adequate' category. The company filed this disclosure with the stock exchanges under SEBI's listing regulations.
This is a neutral disclosure. An 'Adequate' ESG rating signals decent but not leading sustainability practices, and is unlikely to move the stock meaningfully. It may be useful for ESG-focused investors and funds that screen companies on sustainability metrics.